Particle Flow Gaussian Particle Filter [PDF]
arXiv, 2022 State estimation in non-linear models is performed by tracking the posterior distribution recursively. A plethora of algorithms have been proposed for this task. Among them, the Gaussian particle filter uses a weighted set of particles to construct a Gaussian approximation to the posterior.
arxiv
Factors that affect the intracellular localization and trafficking of African horse sickness virus core protein, VP7 [PDF]
, 2014 African horse sickness virus (AHSV) VP7 is the major core protein of the virion. Apart from its role in virus assembly, VP7 forms crystalline-like particles during infection and when expressed in insect cells. The aim of this study was to investigate the
Bekker, Shani +2 more
core +1 more source
Escherichia coli-derived virus-like particles in vaccine development
npj Vaccines, 2017 Recombinant virus-like particle-based vaccines are composed of viral structural proteins and mimic authentic native viruses but are devoid of viral genetic materials. They are the active components in highly safe and effective vaccines for the prevention
Xiaofen Huang +4 more
doaj +1 more source
Two-Particle Circular Billiards Versus Randomly Perturbed One-Particle Circular Billiards [PDF]
Chaos 23, 013123 (2013), 2012 We study a two-particle circular billiard containing two finite-size circular particles that collide elastically with the billiard boundary and with each other. Such a two-particle circular billiard provides a clean example of an "intermittent" system.
arxiv +1 more source
Virus-like particle display of HER2 induces potent anti-cancer responses
Oncoimmunology, 2018 Overexpression of human epidermal growth factor receptor-2 (HER2) occurs in 20–30% of invasive breast cancers. Monoclonal antibody therapy is effective in treating HER2-driven mammary carcinomas, but its utility is limited by high costs, side effects and
A. Palladini +18 more
semanticscholar +1 more source
VIRUS-LIKE PARTICLE VACCINE MANUFACTURING FROM YEAST [PDF]
, 2020 Influenza virus has an intrinsic nature to undergo mutations. Hence, there have been struggles to combat this disease since the time when the worst influenza pandemic first hit in 1918.
Ananya, Ananya
core +1 more source
Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms
Viruses, 2020 Hepatitis B remains one of the major global health problems more than 40 years after the identification of human hepatitis B virus (HBV) as the causative agent.
Joan Kha-Tu Ho +2 more
doaj +1 more source
Virus-Like Particle-Mediated Vaccination against Interleukin-13 May Harbour General Anti-Allergic Potential beyond Atopic Dermatitis [PDF]
, 2020 Virus-like particle (VLP)-based anti-infective prophylactic vaccination has been established in clinical use. Although validated in proof-of-concept clinical trials in humans, no VLP-based therapeutic vaccination against self-proteins to modulate chronic
Foerster, John, Molęda, Aleksandra
core +2 more sources
Immunogenicity of Virus Like Particle Forming Baculoviral DNA Vaccine against Pandemic Influenza H1N1. [PDF]
PLoS ONE, 2016 An outbreak of influenza H1N1 in 2009, representing the first influenza pandemic of the 21st century, was transmitted to over a million individuals and claimed 18,449 lives.
Yong-Dae Gwon +9 more
doaj +1 more source
Bioanalytics for Influenza Virus-Like Particle Characterization and Process Monitoring
Frontiers in Bioengineering and Biotechnology, 2022 Virus-like particles (VLPs) are excellent platforms for the development of influenza vaccine candidates. Nonetheless, their characterization is challenging due to VLPs’ unique biophysical and biochemical properties. To cope with such complexity, multiple
Sofia B. Carvalho +12 more
doaj +1 more source